Pulsed Thulium:Yag, Thulium Fiber, and Holmium:Yag Lasers in Mini-PCNL: A Three-Arm Comparative Cohort Study

Background & Objectives: Laser lithotripsy is the standard energy source for mini-percutaneous nephrolithotomy (mini-PCNL). Although Holmium:YAG (Ho:YAG), Thulium Fiber Laser (TFL), and pulsed Thulium:YAG (p-Tm:YAG) are currently available for clinical use, direct comparisons among all three laser technologies are lacking. This study aimed to compare the efficacy, safety, and procedural performance of Ho:YAG, TFL, and p-Tm:YAG during mini-PCNL. The primary endpoint was the stone-free rate (SFR). Secondary outcomes included complications, operative time, lasing time, total energy delivered, and laser-related procedural metrics. Methods: Consecutive patients treated with p-Tm:YAG during mini-PCNL for renal stones were prospectively enrolled and compared with two cohorts from our institutional database treated with Ho:YAG or TFL. All procedures were performed using the same mini-PCNL technique and predefined laser settings selected to achieve the closest technically feasible match among the three platforms. Results: Ninety patients were included (30 per group). No significant differences in SFR were observed among Ho:YAG, TFL, and p-Tm:YAG (p = 0.93), or in overall complication rates (p = 0.93). After adjusting for stone volume, density, composition, and location, the laser platform was not independently associated with SFR, whereas stone volume was the only independent predictor of stone-free status. TFL exhibited a significantly longer operative time than Ho:YAG and a longer lasing time than both Ho:YAG and p-Tm:YAG, and was associated with greater total energy delivery, lower ablation efficiency, and lower ablation speed. Conversely, p-Tm:YAG demonstrated a significantly shorter lasing time than TFL and an ablation efficiency similar to that of Ho:YAG, with lasing time and ablation speed values between those observed with Ho:YAG and TFL under the evaluated settings. Laser efficacy did not differ significantly among the three groups. Conclusions: No significant differences in stone-free or safety outcomes were observed among the three laser platforms in mini-PCNL. Although significant differences were observed in lasing time, ablation speed, and energy utilization, p-Tm:YAG demonstrated an intermediate procedural profile under the operating parameters evaluated in this study. Overall, the present findings suggest that p-Tm:YAG represents a feasible treatment option for mini-PCNL, although larger randomized studies are needed before firm conclusions regarding relative platform performance can be drawn.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-09-11
DOI
https://doi.org/10.3390/jcm15187049
Primary Topic
Kidney Stones and Urolithiasis Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Pulsed Thulium:Yag, Thulium Fiber, and Holmium:Yag Lasers in Mini-PCNL: A Three-Arm Comparative Cohort Study

Silvia Proietti, Guido Giusti, Jorge Augusto Alcacio-Mendoza, C.A. Hernandez Gaytan et al.
Journal of Clinical Medicine
Kidney Stones and Urolithiasis Treatments
article

Pulsed Thulium:Yag, Thulium Fiber, and Holmium:Yag Lasers in Mini-PCNL: A Three-Arm Comparative Cohort Study

Silvia Proietti, Guido Giusti, Jorge Augusto Alcacio-Mendoza, C.A. Hernandez Gaytan, Franco Gaboardi
article en

Abstract

Background & Objectives: Laser lithotripsy is the standard energy source for mini-percutaneous nephrolithotomy (mini-PCNL). Although Holmium:YAG (Ho:YAG), Thulium Fiber Laser (TFL), and pulsed Thulium:YAG (p-Tm:YAG) are currently available for clinical use, direct comparisons among all three laser technologies are lacking. This study aimed to compare the efficacy, safety, and procedural performance of Ho:YAG, TFL, and p-Tm:YAG during mini-PCNL. The primary endpoint was the stone-free rate (SFR). Secondary outcomes included complications, operative time, lasing time, total energy delivered, and laser-related procedural metrics. Methods: Consecutive patients treated with p-Tm:YAG during mini-PCNL for renal stones were prospectively enrolled and compared with two cohorts from our institutional database treated with Ho:YAG or TFL. All procedures were performed using the same mini-PCNL technique and predefined laser settings selected to achieve the closest technically feasible match among the three platforms. Results: Ninety patients were included (30 per group). No significant differences in SFR were observed among Ho:YAG, TFL, and p-Tm:YAG (p = 0.93), or in overall complication rates (p = 0.93). After adjusting for stone volume, density, composition, and location, the laser platform was not independently associated with SFR, whereas stone volume was the only independent predictor of stone-free status. TFL exhibited a significantly longer operative time than Ho:YAG and a longer lasing time than both Ho:YAG and p-Tm:YAG, and was associated with greater total energy delivery, lower ablation efficiency, and lower ablation speed. Conversely, p-Tm:YAG demonstrated a significantly shorter lasing time than TFL and an ablation efficiency similar to that of Ho:YAG, with lasing time and ablation speed values between those observed with Ho:YAG and TFL under the evaluated settings. Laser efficacy did not differ significantly among the three groups. Conclusions: No significant differences in stone-free or safety outcomes were observed among the three laser platforms in mini-PCNL. Although significant differences were observed in lasing time, ablation speed, and energy utilization, p-Tm:YAG demonstrated an intermediate procedural profile under the operating parameters evaluated in this study. Overall, the present findings suggest that p-Tm:YAG represents a feasible treatment option for mini-PCNL, although larger randomized studies are needed before firm conclusions regarding relative platform performance can be drawn.

Journal of Clinical MedicineVol. 15(18)
Vita-Salute San Raffaele University (IT), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Affordable and clean energy
Openalex Percentile: Top 11%
Kidney Stones and Urolithiasis Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.